Collectively, these results thus extend a previous study in BC patients on the prognostic role of CD8+ CD103+ Trm cells as a whole12 and pinpoint those T cells that are preferentially associated with delayed tumor growth with enhanced precision. This evidence concerns the gene CD8A and breast cancer.